BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 32233339)

  • 1. Human Adipose-Derived Pericytes: Biological Characterization and Reprogramming into Induced Pluripotent Stem Cells.
    Ahmed TA; Shousha WG; Abdo SM; Mohamed IK; El-Badri N
    Cell Physiol Biochem; 2020 Apr; 54(2):271-286. PubMed ID: 32233339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and characterization of mesenchymal stem cells from the sub-amniotic human umbilical cord lining membrane.
    Kita K; Gauglitz GG; Phan TT; Herndon DN; Jeschke MG
    Stem Cells Dev; 2010 Apr; 19(4):491-502. PubMed ID: 19635009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells from the Tasmanian Devil (
    Weeratunga P; Shahsavari A; Fennis E; Wolvetang EJ; Ovchinnikov DA; Whitworth DJ
    Stem Cells Dev; 2020 Jan; 29(1):25-37. PubMed ID: 31709909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of mesenchymal stem cells from whole human umbilical cord applying a single enzyme approach.
    Zhang H; Zhang B; Tao Y; Cheng M; Hu J; Xu M; Chen H
    Cell Biochem Funct; 2012 Dec; 30(8):643-9. PubMed ID: 22777760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells Are Functionally and Genetically Different From Bone Marrow-Derived Mesenchymal Stromal Cells.
    Xu M; Shaw G; Murphy M; Barry F
    Stem Cells; 2019 Jun; 37(6):754-765. PubMed ID: 30779868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions.
    Slamecka J; Salimova L; McClellan S; van Kelle M; Kehl D; Laurini J; Cinelli P; Owen L; Hoerstrup SP; Weber B
    Cell Cycle; 2016; 15(2):234-49. PubMed ID: 26654216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient Reprogramming of Canine Peripheral Blood Mononuclear Cells into Induced Pluripotent Stem Cells.
    Kimura K; Tsukamoto M; Tanaka M; Kuwamura M; Ohtaka M; Nishimura K; Nakanishi M; Sugiura K; Hatoya S
    Stem Cells Dev; 2021 Jan; 30(2):79-90. PubMed ID: 33256572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of equine induced pluripotent stem cells into mesenchymal lineage for therapeutic use.
    Chung MJ; Park S; Son JY; Lee JY; Yun HH; Lee EJ; Lee EM; Cho GJ; Lee S; Park HS; Jeong KS
    Cell Cycle; 2019 Nov; 18(21):2954-2971. PubMed ID: 31505996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multipotency and cardiomyogenic potential of human adipose-derived stem cells from epicardium, pericardium, and omentum.
    Wystrychowski W; Patlolla B; Zhuge Y; Neofytou E; Robbins RC; Beygui RE
    Stem Cell Res Ther; 2016 Jun; 7(1):84. PubMed ID: 27296220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reprogramming human endometrial fibroblast into induced pluripotent stem cells.
    Chen YJ; Liou YJ; Chang CM; Li HY; Chen CY; Twu NF; Yen MS; Chang YL; Peng CH; Chiou SH; Chen CP; Chao KC
    Taiwan J Obstet Gynecol; 2012 Mar; 51(1):35-42. PubMed ID: 22482966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cocktail of Chemical Compounds and Recombinant Proteins Robustly Promote the Stemness of Adipose-Derived Stem Cells.
    Guo Y; Yu Q; Mathew S; Lian R; Xue Y; Cui Z; Li S; Zhu D; Han Y; Zeng Q; Liu S; Chen J
    Cell Reprogram; 2017 Dec; 19(6):363-371. PubMed ID: 29215942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NANOG Plays a Hierarchical Role in the Transcription Network Regulating the Pluripotency and Plasticity of Adipose Tissue-Derived Stem Cells.
    Pitrone M; Pizzolanti G; Tomasello L; Coppola A; Morini L; Pantuso G; Ficarella R; Guarnotta V; Perrini S; Giorgino F; Giordano C
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28545230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass cytometry-based single-cell analysis of human stem cell reprogramming uncovers differential regulation of specific pluripotency markers.
    Im I; Son YS; Jung KB; Kang I; Teh BE; Lee KB; Son MY; Kim J
    J Biol Chem; 2019 Dec; 294(49):18547-18556. PubMed ID: 31570522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visualization of sequential conversion of human intermediately reprogrammed stem cells into iPS cells.
    Teshigawara R; Hirano K; Nagata S; Huang D; Tada T
    Genes Cells; 2019 Oct; 24(10):667-673. PubMed ID: 31386786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating Reprogramming Efficiency and Pluripotency of the Established Human iPSCS by Pluripotency Markers.
    Cevallos RR; Hossain ME; Zhang R; Hu K
    Methods Mol Biol; 2021; 2239():235-249. PubMed ID: 33226623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-genetic direct reprogramming and biomimetic platforms in a preliminary study for adipose-derived stem cells into corneal endothelia-like cells.
    Dai Y; Guo Y; Wang C; Liu Q; Yang Y; Li S; Guo X; Lian R; Yu R; Liu H; Chen J
    PLoS One; 2014; 9(10):e109856. PubMed ID: 25333522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro characterization of canine multipotent stromal cells isolated from synovium, bone marrow, and adipose tissue: a donor-matched comparative study.
    Bearden RN; Huggins SS; Cummings KJ; Smith R; Gregory CA; Saunders WB
    Stem Cell Res Ther; 2017 Oct; 8(1):218. PubMed ID: 28974260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pericyte plasticity - comparative investigation of the angiogenic and multilineage potential of pericytes from different human tissues.
    Herrmann M; Bara JJ; Sprecher CM; Menzel U; Jalowiec JM; Osinga R; Scherberich A; Alini M; Verrier S
    Eur Cell Mater; 2016 Apr; 31():236-49. PubMed ID: 27062725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of mesenchymal stem cell subpopulations from human amniotic membrane with dissimilar osteoblastic potential.
    Leyva-Leyva M; Barrera L; López-Camarillo C; Arriaga-Pizano L; Orozco-Hoyuela G; Carrillo-Casas EM; Calderón-Pérez J; López-Díaz A; Hernandez-Aguilar F; González-Ramírez R; Kawa S; Chimal-Monroy J; Fuentes-Mera L
    Stem Cells Dev; 2013 Apr; 22(8):1275-87. PubMed ID: 23211052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells.
    Ohmine S; Dietz AB; Deeds MC; Hartjes KA; Miller DR; Thatava T; Sakuma T; Kudva YC; Ikeda Y
    Stem Cell Res Ther; 2011 Nov; 2(6):46. PubMed ID: 22088171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.